[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Daskalaki et al., 2018 - Google Patents

The influence of culture media upon observed cell secretome metabolite profiles: The balance between cell viability and data interpretability

Daskalaki et al., 2018

View PDF
Document ID
5123031489054354750
Author
Daskalaki E
Pillon N
Krook A
Wheelock C
Checa A
Publication year
Publication venue
Analytica chimica acta

External Links

Snippet

The application of metabolomics to investigating the cell secretome has garnered popularity owing to the method's large-scale data output, biochemical insight, and prospects for novel target compound discovery. However, there are no standardized protocols for the use of cell …
Continue reading at www.metabolomics.se (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Similar Documents

Publication Publication Date Title
Daskalaki et al. The influence of culture media upon observed cell secretome metabolite profiles: The balance between cell viability and data interpretability
Li et al. TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples
Gertsman et al. Promises and pitfalls of untargeted metabolomics
Bekker-Jensen et al. Rapid and site-specific deep phosphoproteome profiling by data-independent acquisition without the need for spectral libraries
Tsugawa et al. A cheminformatics approach to characterize metabolomes in stable-isotope-labeled organisms
Meng et al. Simultaneous 3-nitrophenylhydrazine derivatization strategy of carbonyl, carboxyl and phosphoryl submetabolome for LC-MS/MS-based targeted metabolomics with improved sensitivity and coverage
Klein et al. Isotope labeling experiments in metabolomics and fluxomics
García‐Cañaveras et al. LC‐MS untargeted metabolomic analysis of drug‐induced hepatotoxicity in HepG2 cells
Mohmad-Saberi et al. Metabolomics profiling of extracellular metabolites in CHO-K1 cells cultured in different types of growth media
Manier et al. Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
JP2016119903A (en) Metabolic biomarkers of drug-induced cardiotoxicity
Gu et al. In-sample calibration curve using multiple isotopologue reaction monitoring of a stable isotopically labeled analyte for instant LC-MS/MS bioanalysis and quantitative proteomics
Carson et al. Imaging regiospecific lipid turnover in mouse brain with desorption electrospray ionization mass spectrometry [S]
Millard et al. Isotopic studies of metabolic systems by mass spectrometry: using Pascal’s triangle to produce biological standards with fully controlled labeling patterns
Yu et al. Patterned signal ratio biases in mass spectrometry-based quantitative metabolomics
Wiśniewski et al. Absolute protein quantification allows differentiation of cell‐specific metabolic routes and functions
Fritsche-Guenther et al. Progression-dependent altered metabolism in osteosarcoma resulting in different nutrient source dependencies
Kani Quantitative proteomics using SILAC
Violante et al. Stable isotope tracers for metabolic pathway analysis
Tang et al. Estimation value of plasma amino acid target analysis to the acute radiation injury early triage in the rat model
Sagi-Kiss et al. Ion-pairing chromatography and amine derivatization provide complementary approaches for the targeted LC-MS analysis of the polar metabolome
Wang et al. MS-IDF: a software tool for nontargeted identification of endogenous metabolites after chemical isotope labeling based on a narrow mass defect filter
Jiang et al. Cross-platform metabolomics investigating the intracellular metabolic alterations of HaCaT cells exposed to phenanthrene
Ramirez-Hincapie et al. A high-throughput metabolomics in vitro platform for the characterization of hepatotoxicity
Manier et al. Current situation of the metabolomics techniques used for the metabolism studies of new psychoactive substances